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Background: The diagnosis of COPD is dependent upon clinical judgment and confirmation 
of the presence of airflow obstruction using spirometry. Spirometry is now routinely available; 
however, spirometry incorrectly performed or interpreted can lead to misdiagnosis. We aimed to 
determine whether spirometry undertaken in primary care for patients suspected to have COPD 
was of sufficient quality and whether their spirometry was correctly interpreted.
Methods: Two chest physicians re-read all spirometric readings for both quality of the pro-
cedure and interpretation, received as a part of COPD validation studies using data from the 
Clinical Practice Research Datalink (CPRD). We then used logistic regression to investigate 
predictors of correct interpretation.
Results: Spirometry traces were obtained for 306 patients, of which 221 (72.2%) were conducted 
in primary care. Of those conducted in primary care, 98.6% (n=218) of spirometry traces were 
of adequate quality. Of those traces that were of adequate quality and conducted in primary care, 
and in whom a general practitioner (GP) diagnosis of COPD had been made, 72.5% (n=218) 
were consistent with obstruction. Historical records for asthma diagnosis significantly decreased 
odds of correct interpretation.
Conclusion: The quality of the spirometry procedure undertaken in primary care is high. 
However, this was not reflected in the quality of interpretation, suggesting an unmet training in 
primary care. The quality of the spirometry procedure as demonstrated by spirometric tracings 
provides a re-assurance for the use of spirometric values available in the electronic health care 
record databases for research purposes.
Keywords: pulmonary disease, chronic obstructive, general practice, respiratory function tests, 
data accuracy, electronic health records
Introduction
COPD and exacerbations of COPD represent an enormous health burden worldwide. 
Currently, COPD is the third leading cause of death worldwide.1 In England and 
Wales alone, ~25,000 people a year die of COPD, and between 2007 and 2009, COPD 
accounted for 4.8% of all deaths in England.2 There are ~1.2 million people living 
with COPD in the UK.3
There is no single diagnostic test for COPD. The diagnosis relies on clinical judg-
ment based on a combination of history, physical examination, and confirmation of the 
presence of airflow obstruction using spirometry.4 Spirometry is now more routinely 
available and is used as standard to determine severity of airflow limitation in COPD 
patients in epidemiological studies rather than drug treatments as a proxy, which have 
previously been used.5 However, spirometry if incorrectly performed or interpreted can 
lead to misdiagnosis (both over and under diagnosis of COPD). Common errors in the 
performance of spirometry that would impact on quality and therefore interpretability 
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include, for example, submaximal inhalation, variable effort, 
extra breaths, or coughing during the procedure. Common 
possible errors in interpretation include not appreciating that 
the quality is insufficient or can arise from the use of inap-
propriate reference values. Previous work conducted over 
a decade ago, before the introduction of the Quality and 
Outcomes Framework (QOF), found that both the perfor-
mance and the interpretation of spirometry for the diagnosis 
of COPD in UK primary care were low.6 Over half of those 
with a diagnosis of COPD had significant reversibility of 
obstruction (range 210–800 mL), and almost one-third had 
normal lung function.6 Another study conducted in the UK 
primary care in 2007 further concluded that the quality of 
conduct of spirometry in primary care was also low (32% of 
tests were of unacceptable quality).7
Knowing that primary care electronic health care record 
(EHR) spirometry data are accurate is important as many 
respiratory diseases are diagnosed and managed in primary 
care. Additionally, observational research can use data 
entered into EHR both as single measurements to determine 
severity of airflow obstruction for study population descrip-
tion and statistical modeling as a covariate and to track 
changes in lung function over time as disease progression 
outcomes. In a recent COPD validation study in Clinical 
Practice Research Datalink (CPRD), it was found that use 
of confirmation of COPD diagnosis by spirometry did not 
greatly improve the validity of the definition of COPD in 
the CPRD, thus raising questions about the validity and 
interpretation of spirometry in this setting.8
Using data from the CPRD, we aimed to determine 
whether spirometry undertaken in primary care for patients 
suspected to have COPD was of sufficient quality and whether 
the spirometry was subsequently correctly interpreted.
Methods
Data sources
The CPRD is a large, longitudinal electronic database of 
primary care medical records that contains anonymized 
records for .13 million patients, of whom 4.4 million are 
currently registered with a practice that is contributing data 
to the CPRD, representing ~9% of the UK population.9 Data 
held include information on consultations, diagnoses, tests 
(including spirometry), and referrals to secondary care and 
prescriptions from primary care and some lifestyle data. Data 
are predominately recorded using a system of “Read codes”, 
a hierarchical system of codes that describe multiple phe-
nomena, including diagnoses, clinical signs, symptoms, and 
lifestyle characteristics. Additionally, actual test values are 
recorded in some fields under the heading of entity types.
study population
As part of previous studies to validate the recording of COPD 
diagnosis and exacerbations of COPD in CPRD,8,10 along 
with a questionnaire, general practitioners (GPs) were asked 
to send additional information (including spirometry traces) 
that may have supported or refuted a diagnosis of COPD. 
GPs also indicated whether they thought the patient had 
COPD and if the patient had received a diagnosis of any other 
respiratory disease. Patients were only included in this study 
if the additional supporting information sent by GPs included 
spirometry traces. We were able to obtain further clinical 
and demographic characteristics of these patients from their 
CPRD record. Data were “twice encrypted” within CPRD 
to ensure anonymity, first between practices and CPRD and 
second from CPRD to researchers.
assessment of quality and interpretation 
of spirometry
For both the previous validation studies, two respiratory phy-
sicians (JKQ and JRH) assessed all available spirometry traces 
for 1) quality and 2) diagnostic interpretation. Spirometry 
quality was judged by examining the flow volume loop 
according to American Thoracic Society/European Respiratory 
Society (ATS/ERS) criteria.11 Briefly, spirometry was judged 
to be of low quality if it had any of the following features: 
insufficient expiratory time (,6 seconds), incomplete expira-
tion (determined by absence of volume–time plateau from 
the flow volume loop), evidence of coughing, expiration was 
too slow (determined from the flow volume loop), or there 
was no evidence of reproducibility. We followed ATS/ERS 
guidelines for repeatability criteria: three technically accept-
able results should be selected from up to five efforts, repeat-
ability criteria that are met when there is no .100 mL ideally 
(and certainly no .150 mL in the occasional highly variable 
patient) between each blow.
Spirometry results were classified by an independent 
respiratory physician (JKQ) as 1) normal, 2) indicative of 
obstruction, 3) indicative of restriction, or 4) mixed obstruc-
tion and restriction. We used the ATS/ERS guidelines to 
guide interpretation.12 Obstruction was defined as expiratory 
volume in one second (FEV
1
)/forced vital capacity (FVC) 
ratio , lower limit of normal (LLN). Restriction was defined 
as FVC ,85% predicted and FEV
1
/FVC $0.55. Those 
with both obstruction and restriction were categorized as 
having a mixed defect. Those traces with no evidence of 
obstruction or restriction were considered to be normal. We 
did not assess reversibility. Interpretation of spirometry by 
health practitioners in the primary care setting was obtained 
from questionnaires, and additional material returned with 
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questionnaires. Diagnostic interpretation of the spirometry 
traces by the respiratory physician was taken to be the ref-
erence standard, and interpretations of health practitioners 
in the primary care setting were compared to this. We were 
unable to tell who within the GP practice had actually per-
formed the spirometry.
analysis
The primary analysis focused on the accuracy of identi-
fication of a COPD diagnosis in the presence of a valid 
spirometry trace. Logistic regression was used to assess 
predictors of primary care health practitioner interpretation 
of spirometric traces with the outcome of COPD diagnosis 
confirmed or not confirmed by respiratory physician adjudi-
cation of spirometry traces. Age, sex, and previous record for 
asthma diagnosis were covariates. Additionally, bronchodi-
lators before spirometry status was used as a covariate in a 
sensitivity regression model restricted to those where it was 
clear from the spirometry report if it was conducted pre- or 
post-bronchodilator (n=78).
ethics
Ethical approval was obtained from the London School of 
Hygiene and Tropical Medicine (LSHTM) Observational 
Research Ethics Committee (approval numbers 6481 and 
6204) and the CPRD Independent Scientific Advisory 
Committee (ISAC) (approval number 12_065A). Patient 
records and questionnaire responses were de-identified and 
anonymized by CPRD staff before being sent to the investiga-
tors. The ISAC protocol is available on request.
Results
Spirometry traces were obtained for 306 patients, of which 
230 (75.1%) were conducted in primary care (Figure 1). 
The characteristics of the patients included in the study 
are presented in Table 1. Briefly, 47.7% were female; the 
Figure 1 Flow diagram of patient entry into the study (n=222).
Abbreviation: aeCOPD, acute exacerbation of COPD.
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mean age was 63.1 years (standard deviation [SD] 10.0). 
The sample was evenly split among males and females and 
among ex-smokers and current smokers. Almost 30% had a 
previous GP diagnosis of asthma.
In total, 56.7% (n=161) of the traces were obtained 
as part of the acute exacerbation of COPD (AECOPD) 
validation study and the remaining as part of the COPD 
validation study.
Of those conducted in primary care, 96.5% (n=222) of 
spirometry traces were of adequate quality such that a valid 
interpretation could be made.
Of those traces that were conducted in primary care 
and were of acceptable quality, 27.9% (n=62) of the traces 
were definitely conducted post-bronchodilator and 7.2% 
(n=16) were definitely conducted pre-bronchodilator. For 
the remaining (64.9%, n=144), it was unclear if spirometry 
was conducted pre- or post-bronchodilator.
Of those traces that were of adequate quality and con-
ducted in primary care, and in whom a GP diagnosis of COPD 
had been made, 72.5% (158) of the spirometry traces labeled 
as COPD were consistent with obstruction (Table 2).
Regression models indicated that correct interpretation 
of spirometry (as obstructive, restrictive, or normal) was 
influenced by a record for a previous asthma diagnosis 
(odds ratio [OR] 0.49, 95% confidence interval [95% CI] 
0.26–0.93). There was no evidence that correct interpretation 
was influenced by age, sex, or whether the spirometry was 
conducted pre- or post-bronchodilator (Table 3).
Discussion
We found the quality of spirometry undertaken in primary 
care to be high (.96% had acceptable quality), with gaps 
in validity of interpretation in primary care. This suggests 
a large improvement in the quality of spirometry; however, 
it seems that the validity of interpretation of spirometry has 
improved only modestly over the last decade.
strengths and limitations
One of the strengths of this work is the representativeness of 
the CPRD database. Our findings are also strengthened by the 
fact we were able to review actual traces. However, we could 
not always tell whether traces were performed pre- or post-
bronchodilator, again highlighting a clinically important area 
in terms of coding in records. This limitation means that we 
could not stratify patients into pre- and post-bronchodilator 
for the analysis. In the UK, patients with COPD should have 
spirometry conducted every 15 months. As such, it is likely 
that most traces were conducted in people who the GP has 
already diagnosed with COPD. A substantial proportion 
of these patients will be using long-term bronchodilators, 
and as such, their spirometry will be “post-bronchodilator”. 
We appreciate also that our responders might not be truly 
representative of all GPs and we could not tell who within 
the practice was actually performing and interpreting the 
spirometry traces.
Comparison with existing literature
Compared to work conducted over a decade ago,6 we found a 
large improvement in the quality of spirometry conducted in 
Table 1 Characteristics of included patients with interpretable 
spirometry conducted in primary care (n=222)
Characteristics n (%)
age group, years
,55 52 (23.4)
55–64 81 (36.5)
65–74 63 (28.4)
75+ 26 (11.7)
sex
Male 117 (52.7)
Female 105 (47.3)
smoking status
ex-smoker 106 (47.8)
Current smoker 116 (52.3)
Previous gP diagnosis of asthma
Yes 67 (30.2)
no 155 (69.8)
Abbreviation: gP, general practitioner.
Table 2 respiratory physician interpretation of spirometry for 
patients diagnosed with COPD in primary care (n=218)
Respiratory physician 
spirometry interpretation
n (%)
normal 52 (23.4)
Obstructive 159 (71.6)
restrictive 9 (4.1)
Mixed obstructive and restrictive 2 (0.9)
Table 3 Predictors of correct interpretation of valid spirometry 
traces carried out in primary care (n=222)
Characteristics Crude OR 
(95% CI)
Adjusted OR 
(95% CI)*
age (per year) 0.98 (0.96–1.01) 0.98 (0.96–1.01)
Female sex 1.26 (0.69–2.30) 1.28 (0.69–2.38)
Previous gP diagnosis of asthma 0.50 (0.27–0.94) 0.49 (0.26–0.93)
spirometry conducted 
post-bronchodilator**
0.62 (0.20–2.03) 0.61 (0.18–2.09)
Notes: *adjusted for other characteristics in the table. **reference category is 
spirometry conducted pre-bronchodilator. excluding traces where it was unclear if 
spirometry was conducted pre- or post-bronchodilator.
Abbreviations: OR, odds ratio; CI, confidence interval; GP, general practitioner.
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primary care; however, the proportion of those with correctly 
interpreted spirometry was not markedly improved. Previous 
work has suggested that age and sex influenced interpretation 
of spirometry for diagnosis of COPD.13 We did not find that 
age or sex influenced accuracy of interpretation; this may 
have been due to lower power in our study to detect these 
differences. We found that a previous asthma diagnosis, 
however, decreased the probability that a valid interpretation 
would be made.
Implications for research and practice
Our results suggest that when undertaking research in UK 
primary care databases, such as CPRD, it is better to use 
actual values recorded for spirometry rather than relying 
on the interpretation Read codes entered into the patient’s 
record. In our previous study that validated the recording 
of COPD in UK EHR, we found that by using a diagnostic 
code for COPD combined with a smoking history resulted in 
an algorithm for the ascertainment of COPD that had a high 
positive predictive value.8 Although we did not investigate 
the utility of addition of an obstructive spirometric ratio to 
the algorithm, when we assessed the addition of a marker 
indicating whether or not spirometry was performed, this did 
not improve the positive predictive value. This suggested 
that interpretation of spirometry for the diagnosis of COPD 
might be less than ideal, a finding reflected in the results 
from this study. Our results are also important clinically, as 
they indicate an unmet training need within primary care in 
the interpretation of spirometry results.
According to guidelines for clinical care, COPD patients 
should have their diagnosis confirmed by spirometry within 
12 months of diagnosis and should have their FEV
1
 monitored 
yearly. Both of these recommendations are incentivized by 
QOF. This means that the CPRD is potentially a rich source 
of valid longitudinal information on spirometry results. FEV
1
 
is an important outcome in COPD studies. Demonstrating 
the validity of FEV
1
 values in CPRD means that researchers 
can use this resource to study FEV
1
 as an outcome in COPD 
studies, such as those investigating COPD disease epidemiol-
ogy or the effects of interventions.
Conclusion
Spirometry is performed in primary care to a high standard. 
However, interpretation of spirometry in patients with sus-
pected COPD in primary care is moderate. Entered values 
from spirometry are valid and can be used for research. 
Efforts should be made to improve spirometry interpretation 
for high-quality patient care.
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